Haemonetics (HAE) Net Cash Flow (2009 - 2026)

Haemonetics has reported Net Cash Flow for 18 years, with the latest figure at -$117.2 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 595.25% year-over-year to -$117.2 million; the trailing twelve-month figure through Mar 2026 stood at -$64.8 million (down 150.36% YoY), and the FY2026 full-year result was -$64.8 million, down 150.36% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$117.2 million, down from $66.1 million in the prior quarter.
• The five-year high for Net Cash Flow was $167.1 million in Q2 2024, with the low at -$160.0 million in Q4 2023.
• Average Net Cash Flow over 5 years is $3.3 million, with a median of $3.8 million recorded in 2023.
• Year-over-year, Net Cash Flow sank 635.35% in 2023 and jumped 5077.38% in 2024.
• Tracing HAE's Net Cash Flow over 5 years: stood at -$21.8 million in 2022, then slumped by 635.35% to -$160.0 million in 2023, then jumped by 117.35% to $27.8 million in 2024, then soared by 138.1% to $66.1 million in 2025, then slumped by 277.18% to -$117.2 million in 2026.
• The last three Net Cash Flow figures came in at -$117.2 million (Q1 2026), $66.1 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.

Peer Comparison